Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · Real-Time Price · USD
1.220
+0.010 (0.83%)
Nov 5, 2025, 4:00 PM EST - Market closed
Werewolf Therapeutics Market Cap
Werewolf Therapeutics has a market cap or net worth of $55.79 million as of November 6, 2025. Its market cap has decreased by -37.73% in one year.
Market Cap
55.79M
Enterprise Value
27.38M
1-Year Change
-37.73%
Ranking
Category
Stock Price
$1.22
Market Cap Chart
Since the IPO on April 30, 2021, Werewolf Therapeutics's market cap has decreased from $440.42M to $55.79M, a decrease of -87.33%. That is a compound annual growth rate of -36.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2025 | 55.33M | -16.10% |
| Dec 31, 2024 | 65.95M | -52.79% |
| Dec 29, 2023 | 139.70M | 121.66% |
| Dec 30, 2022 | 63.03M | -80.81% |
| Dec 31, 2021 | 328.47M | -25.42% |
| Apr 30, 2021 | 440.42M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 802.74B |
| Johnson & Johnson | 448.76B |
| AbbVie | 374.44B |
| UnitedHealth Group | 302.36B |
| AstraZeneca | 252.04B |
| Novartis AG | 236.44B |
| Novo Nordisk | 216.34B |
| Abbott Laboratories | 215.34B |